Skip to content
Screener

Reported November 9, 2026 · After market close

Revenue$815.3MMiss by $5.7M
EPS$0.16Beat by $0.05
Revenue estimate$821.0M
EPS estimate$0.11
“Our financial results in the third quarter reflect the impact of the successful Idaho Falls divestiture and sustained momentum in our core business, underscoring the value of our short-stay surgical platform. Additionally, the recently announced amended merger agreement with HealthSpan Partners serves as further validation of our unique offering, while representing a compelling outcome for our patients, physicians, stockholders, and other stakeholders. We are excited to move forward with this next chapter as we continue to deliver high-quality care to all our patients and support our physicians, colleagues and health system partners.”
Eric Evans

Next report

Date not yet announced

Financials

Q3 2026

Income statement

See full
Revenue$815.3M-0.8%
Operating income$85.6M-19.0%
Net income-$21.1M+7.0%
EPS (diluted)-$0.16+11.1%

Balance sheet

See full
Cash & equivalents$354.5M+74.3%
Total debt$4.0B-19.0%
Total equity$1.7B-3.8%
Total assets$7.0B-11.3%

Cash flow

See full
Operating cash flow$103.5M+23.8%
CapEx$24.5M+23.7%
Free cash flow$79.0M+23.8%

Valuation & ratios

Valuation

as of 11/10/26
See full
Market cap$3.41B+65.8%
Enterprise value$7.01B+4.0%
P/S1×+0.4×

Profitability

See full
Operating margin10.8%-1.5pp
Net margin-2.6%-0.9pp
FCF margin6%+0.1pp

Returns & leverage

See full
Return on equity-5.1%-1.6pp
Debt / equity2.4×-0.4×
Current ratio2.2×+0.3×

Segments

By product

See full
Government$380.3M+9.6%
Private insurance$379.6M-6.1%
Other$22.8M+9.1%
Other service revenues$17.3M-24.8%
Self-pay$15.3M-42.3%

By segment

See full
Surgical Facilities$815.3M-0.8%

FAQ

When did Surgery Partners, Inc. report Q3 2026 earnings?
Surgery Partners, Inc. (SGRY) reported Q3 2026 earnings on November 9, 2026 after market close.
What were Surgery Partners, Inc.'s Q3 2026 revenue and EPS?
Surgery Partners, Inc. reported revenue of $815.3M and eps of $0.16 for Q3 2026.
Did Surgery Partners, Inc. beat estimates in Q3 2026?
Revenue missed the consensus estimate of $821.0M by $5.7M. EPS beat the consensus estimate of $0.11 by $0.05.
How did Surgery Partners, Inc.'s Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 0.8% from $821.5M a year earlier and eps grew 23.1% from $0.13.
Where can I find Surgery Partners, Inc.'s Q3 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-124236) and the 10-Q periodic report (0001638833-26-000090) directly on SEC EDGAR. The filing index links above go to sec.gov.